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Abstract 
Purpose: To develop a new and fully validated ion-pair spectrophotometric method for the 
determination of duloxetine hydrochloride (DX). 
Methods: Ion-pair spectrophotometric method was employed for the determination of duloxetine 
hydrochloride (DX) in bulk and pharmaceutical formulations using acidic dye methyl orange (MO) as 
ion-pairing agent at pH 4 (phthalate buffer). The yellow ion-pair complex was extracted with chloroform 
and spectrophotometrically estimated at 420 nm. The developed method was validated according to 
ICH and USP guidelines. 
Results: The ion-pair complex of DX and MO obeyed Beer’s law in the range of 2 - 20 g mL
-1 
of DX 
with a correlation coefficient of 0.998. Recovery was good, with a relative standard deviation (%RSD) of 
0.88 - 1.02; precision (inter-day, 0.878 and intra-day, 0.921) was also within validation limits. The limit of 
detection (LOD) and limit of quantitation (LOQ) were 0.25 and 4 g mL
-1
, respectively. The method 
developed was successfully applied to determine DX in a formulation.  
Conclusion: The developed method is accurate, precise, rugged, robust and reproducible. It is also 
sensitive and specific for the determination of DX in bulk and formulation. 
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INTRODUCTION
Duloxetine hydrochloride (DX) is chemically ((+)-
(S)-N-methyl-3-(1-naphthalenyloxy)-2-thiophene 
propanamine) hydrochloride (Fig 1.). Recently, 
DX was approved by United States Food and 
Drug Administration (US FDA) as a balanced 
selective serotonin and nor-epinephrine re-
uptake inhibitor and is used in the treatment of 
major depressive disorders and diabetic 
peripheral neuropathic pain [1-3]. 
The literature on analytical methods for DX 
revealed that it has been determined by high 
performance liquid chromatography (HPLC) [4-






Figure 1: Structure of DX 
 (HPTLC) [7,8], liquid chromatography-tandem 
mass spectroscopy (LC-MSMS) [9], ultraviolet 
(UV) spectrophotometric [10] and colorimetric 
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methods [11,12]. Recently extractive colorimetric 
methods using bromocresol green, bromothymol 
blue and bromophenol blue as ion-paring 
chromogens was studied but only partially 
validated [11,12]. In general, extractive 
colorimetric procedures are popular for their 
sensitivity and selectivity towards the active 
component of interest [13,14]. Due to the ease of 
this technique, it can be considered for the 
quantitative determination of many 
pharmaceuticals.   
To the best of our knowledge, there are no 
previous reports on the determination of DX 
using methyl orange (MO) as ion-pairing agent. 
Therefore, in the present study, an ion-pair 
extractive spectrophotometric quantitative 
analysis of DX using MO was undertaken. The 
main aim was to develop a simple, accurate, 
precise extractive colorimetric method for the 
determination of DX and validate its suitability for 
assaying the DX content of formulations 
according to the requirements of United States 
Pharmacopeia (USP) and International 
Conference on Harmonization (ICH) guidelines 
for method validation [15,16]. 
EXPERIMENTAL
Chemicals and reagents 
All chemicals were of analytical reagent grade 
procured from Daejung Chemicals & Metals, 
Gyeonggi-do, South Korea. Doubly distilled water 
was used to prepare all solutions. Freshly 
prepared solutions were used for method 
development and validation. Potassium hydrogen 
phthalate buffer solution (pH 4) was prepared by 
standard procedure. Methyl orange (MO, 0.1 
%w/v) was prepared in hot water. Standard 
duloxetine hydrochloride (DX) was obtained from 
Sigma Aldrich and tablets containing 60 mg 
duloxetine (Cymbalta, Eli Lilly and Company)  
were purchased from a retail pharmacy. 
Instrumentation 
A Shimadzu UV mini-1240 UV-Visible 
spectrophotometer with 1 cm quartz cells was 
used for all spectral measurements with 
Shimadzu UV Probe system software (version 
2.1). pH measurements were carried out using a 
calibrated digital pH meter (Neomet pH-200L, 
Seoul, South Korea). 
Standard solution of the drug 
A stock solution of 1 mg mL
-1
 was prepared by 
dissolving DX in alcohol (99 %). Working 
standards were prepared by suitable dilution of 
the standard stock solution. 
Sample preparation 
From the 100 g mL
-1
 working standard solution, 
aliquots were transferred to a series of 
100 ml separating funnels and 1 mL of buffer (pH 
4)  and 1 mL of 0.1 %w/v MO was added to each 
separating funnel and shaken well followed by 
the addition of 10 mL of chloroform. The contents 
were shaken well and kept aside to allow for 
separation. The chloroform layer was separated 
and passed through previously dried anhydrous 
sodium sulphate to remove the water in the 
organic layer.  
Determination of maximum absorbance (max) 
and linearity 
Absorption spectrum of the yellow DX-MO ion-
pair complex was obtained by scanning the 
chromogen extracted using chloroform from 350 
- 600 nm. To determine Beer’s law limit, a 
calibration curve was constructed by plotting 
absorbance against concentration.  
Validation of the method 
For routine use of the method, optimization was 
carried out for rapid and quantitative formation of 
colored ion-pair complexes by a number of 
preliminary experiments. USP [15] and ICH [16] 
guidelines were followed for method validation.
LOD and LOQ 
The limit of detection (LOD) and limit of 
quantitation (LOQ) of the method was 
established using the formula: LOD or LOQ = 
SD a/b, where  = 3 for LOD and 10 for LOQ, 
while SD is standard deviation with intercept (a) 
and slope (b) of the standard graph. 
Precision 
Intra-day precision was calculated by estimating 
the %RSD of DX solution (12 g mL
-1
)  at various 
time intervals (5 times) on the same day, while 
the inter-day precision was calculated by 
estimating the %RSD of DX solution (12 g mL
-1
) 
on five consecutive days 
Accuracy  
Accuracy expresses the agreement between the 
established value and the true value. This was 
achieved by recovery studies, i.e., spiking a 
known quantity of pure drug to a pre-analyzed 
sample and the proposed analysis procedure 
was followed. 
Eryılmaz & Palabıyık 
Trop J Pharm Res, February 2013;12 (1): 95
Application of the developed method to 
formulations 
Twenty commercial DX tablets were weighed 
and the mean tablet weight was calculated 
before they were ground to fine powder. A known 
quantity of the powder was accurately weighed 
and transferred into a 50 mL volumetric flask. 
The volume was made up to mark with alcohol, 
shaken well and filtered through Whatman filter 
paper no. 40. Suitable aliquots of this solution 
were taken for the assay of DX. 
Interference and placebo study 
Studies on interference by common excipients 
that might be used in formulations were carried 
out by mixing a known amount of DX (60 mg) 
with specified amounts of the common excipients 
such as lactose, starch and talc in their 
recommended proportions [15]. The analysis of 
these mixtures was carried out using the above 
procedure and the recovery values for DX were 
determined. Likewise, the mixture of above 
excipients was prepared but without the drug, 
and the same procedure was used for analysis.  
Robustness and ruggedness 
Robustness (effect of deliberate change in 
analytical parameters) was studied by 
determining the amount of DX in the tablets by 
slightly varying the wavelength of determination 
and the dye’s (MO) concentration. Ruggedness 
was established by determining DX in the tablet 
formulation using two different 
spectrophotometer Shimadzu UV mini-1240 
(system I) and SCINCO, Neosys-2000 DRS-UV 
provided with liquid sample analysis port (system 
II) and two different analysts (I and II). The 
results obtained were within the recommended % 
RSD limit (< 2%). 
Study of bench top stability of chromogen 
To study the stability of chromogen, a specified 
quantity of stock solution (1 mg mL
-1
) was mixed 
with the above standardized quantity of buffer 
and MO, kept aside (10 min) for reaction and 
extracted with chloroform.  
RESULTS  
Solvent and buffer 
From the trials, potassium hydrogen phthalate 
buffer was found to be suitable and chloroform 
was chosen as the most suitable solvent for 
extraction among those tested which included 
carbon tetrachloride, dichloromethane and 
diethyl ether. The suitability of chloroform for 
extraction of ion-pair has also been reported by 
other researchers [11-14]. A volume of 1 mL of 
MO (0.1 %w/v) was found to be optimal for 
complete complexation.
Maximum absorbance (max)  
The full scan spectra of DX-MO complex showed 
maximum absorbance at 420 nm (Fig 2a).  
Figure 2b indicates that the formed complex 
obeyed the Beer’s law in the range of 2 - 20g 
mL
-1
. The regression equation for the results was 
y = 0.0515 x - 0.1052 (r = 0.9987). The molar 












































Figure 2: (a) Overlay spectra of DX-MO ion-pair 
complex (b) Linearity plot 
Bench top stability of chromogen 
The absorbance of the chromogen from the time 
of extraction (considered as 0 min) to various 
time intervals was determined and the results 
plotted as absorbance against time (plot not 
shown). The plot shows that the chromogen was 
stable up to 3.5 h.  
Stoichiometry of the reaction 
The drug-dye (DX-MO) stoichiometric ratio was 
calculated by Job’s continuous variation method 
and it was found that DX and MO formed a 1:1 
complex [17].
LOD and LOQ 
LOD and LOQ were 0.25 and 4 g mL
-1
, 
respectively. The low values indicate the high 
sensitivity of the proposed method. 
Assay  
The assay results for the marketed formulation 
(tablets) by the proposed and UV (standard) 
methods [10] were 99.95 and 99.98 %, 
respectively, of the label claim. No significant 
differences were found between the calculated 
and theoretical values, based on t- and F-tests at 
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 Confidence Label claim 
(mg/tab) 




60 99.95 99.98 0.18 0.20 1.4 2.9 
a 
Mean of five determinations; 
b 
The tabulated values of t and F at 95% confidence limit are 2.67 and 6.02 
respectively 
      Table 2: Precision and accuracy 
Precision Accuracy 











75 100.1 1.02 
100 99.83 0.88 12 0.878 0.921 
125 99.93 0.97 
       a 
Mean of five determinations 
95% confidence level, which proves that the 
proposed method is comparable with that of 
reference (standard) method (Table 1). 
Precision and accuracy of the method 
The results obtained for precision of the method 
are given in Table 2. The relative standard 
deviation (%RSD) was low, being 0.878 and 
0.921 % for inter- and intra-day precision, 
respectively, and thus indicates high precision 
(repeatability) of the method. Recovery data are 
also presented in Table 2. Mean %RSD 
determined at three levels was in the range 0.88 
- 1.02 %, indicating good accuracy of the 
proposed method. 
Effect of MO concentration and volume  
The effect of  concentration of MO was studied by 
measuring the absorbance of solutions containing 
DX (12 g mL
-1
), 1 mL of buffer  and 1 mL of MO 
solution at various concentration (0.05 - 0.175 
%w/v). The results are depicted in Fig 3a.  MO 
concentration of 0.1 %w/v gave maximum 
absorbance and it was therefore chosen as most 
suitable for complexation.  
The effect of the volume of MO was studied by 
varying the volume of the added dye (0.5 - 2 mL) 
while maintaining dye concentration at 0.1% w/v 
and drug concentration at 12 g mL
-1
 (Fig 3b).  
The results show that 1 mL of 0.1 %w/v MO was 
enough to form complex as it produced maximum 
absorbance. Larger volumes of reagent had no 
marked effect on ion-pair complex formation. 
Effect of pH 
The effect of pH was studied by analyzing a 
solution containing DX (12 g mL
-1
), 1 mL of 0.1 
%w/v MO and 1 mL of buffer of varying pH of 3.8 - 
4.2. The results showed that 1 mL of buffer with 
pH 4 was suitable for the determination of DX. 
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Figure 3: Plot of absorbance vs. (a) MO concentration 
and (b) MO volume
Interference and placebo influence 
The effect of excipient (lactose, starch and talc) 
interference with the proposed method showed 
that recovery of the drug was 100.09 ± 0.78, 
99.95 ± 0.60 and 99.58 ± 0.50, respectively. 
Since recovery of the drug was high, it therefore 
means that the added excipients had no 
significant effect on the assay. Absence of color 
in the extract obtained from the placebo indicates 
the selectivity of the method.  
Robustness and ruggedness 
As Table 3 shows, the results obtained were 
within the recommended limits for %RSD (< 2%). 
DISCUSSION 
Anionic MO forms an ion-association complex 
with the positively charged quaternary amine of 
DX. The DX-MO complex is a pair of two 
oppositely charged ions of single unit held 
together by an electrostatic force of attraction.  
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419 0.342 0.09 0.546 I 0.125 I 0.156 
421 0.421 0.11 0.798 II 0.752 II 0.963 
   a 
Mean of five determinations 
The formed yellow ion-pair complex showed 
maximum absorbance at 420 nm and obeyed. 
Beer’s law in the concentration range of 2 - 20 
g mL
-1
 with a very good correlation co-efficient 
of 0.9987. The developed method was validated 
for its accuracy, precision, stability, ruggedness 
and robustness. All the studied parameters were 
within limits for validation of analytical methods, 
as prescribed in USP and ICH guidelines with 
respect to %RSD. Furthermore, the interference 
study showed that the method was not affected 
by common excipients used in the study. The 
proposed method, therefore, is in good 
agreement with previously reported methods. 
CONCLUSION 
The developed ion-pair extractive colorimetric 
method for the determination of DX in bulk and in 
tablet formulation is sensitive, specific and rapid. 
The method also showed good accuracy and 
was selective for the drug. Since the developed 
method utilizes simple reagents, it should easily 
be affordable by most analytical laboratories. The 
developed method is thus recommended for 
routine determination of DX in tablet formulations 
validation.  
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